Page 95 - GPD-1-2
P. 95

Gene & Protein in Disease                                                  Structure and function of USP7



            suppression. The tumor suppressive role of p53 protein   Table 2. Signaling pathway regulated by USP7
            has been widely reported, and as a transcriptional factor,
            p53 regulates numerous physiology processes, such as   Signaling pathway  Ref  Signaling pathway  Ref
            cell cycle, DNA damage repair, cell apoptosis, antitumor   p300-p53/p21 pathway  [128]  BCR-ABL signaling  [38]
            activity, and cell stress response [116] . In contrast, mutations   EZH2-CCF-cGAS   [129]  MDM2/MDMX-p53   [130]
            and dysregulation of p53 have been reported to occur in   signaling       pathway
            more than 50% of all malignancies, leading to the loss of   FBP1-DNMT1 pathway  [131]  NEDD4L-SMAD pathway  [132]
            its antitumor activity [117] . The stability of p53 is regulated   Cell cycle and EMT   [133]  JMJD3/CLU signaling  [81]
            through the UPP and its polyubiquitination, and mediated   pathway
            by HDM2, an E3 Ub ligase [118] . Interestingly, HDM2 is   p53/TfR1 pathway  [134]  Wnt/β-catenin signaling  [39]
            also degraded through the UPP in an autoubiquitination   PI3K/Akt pathway  [124]  Hippo pathway  [107]
            pattern, at the same time p53 and HDM2 interacts with   Akt/ERK signaling  [135]  NF-κB signaling  [136]
            each  other  by  forming  a  feedback  loop [119] .  Interestingly,   AMPK pathway  [124]  Shh pathway  [16]
            USP7 can regulate both p53 and mouse double minute
            2 homolog (MDM2). USP7 interacts with p53 through   NOX4/NLRP3 pathway  [137]  Glucose Metabolism   [138]
                                                                                      signaling
            its TRAF-like domain and stabilizes the p53 protein
            level  by  decreasing  its  ubiquitination level, even  in  the   So×9-PTHrP-PTH1R   [58]  Insulin/IGF-1-like   [88]
                                                                                      signaling
                                                               axis
                           [24]
            presence of HDM2 . Meanwhile, USP7 also binds with
                                              [21]
            HDM2 and inhibits its polyubiquitination . Thus, these   HIF-1α signaling   [139]  Hedgehog signaling  [140]
                                                               pathway
            three  proteins  form  a  complex,  as evidenced  by their   Shoc2-ERK1/2 pathway  [141]  p53-MDM2 pathway  [21]
            crystal structure analyses, where both HDM2 and p53
            interacts with the TRAF-like domain of USP7, further, the
            interaction of HDM2/USP7 is closer than p53/USP7 [120,121] .   systems, USP7 directly interacts with and stabilizes
            The previous studies have shown that partial knockdown of   Axin protein by decreasing its polyubiquitination and
            USP7 induces the degradation of p53, while the complete   inhibiting the Wnt/β-catenin pathway thereby suppressing
                                                                                               [39]
            inhibition of USP7 expression leads to the stabilization   Wnt-induced osteoblast differentiation . In addition,
            of p53, and this phenomenon is related to HDM2 [21,122] .   Hippo pathway is essential to the organ development,
            Another study reported that USP7 stabilizes both p53 and   and its deregulation has been identified in a wide variety
            HDM2 protein in vivo. However, it is believed that USP7   of tumors. Further, a transcription coactivator Yorkie
            maintains HDM2 to a certain protein level, to regulate the   has been demonstrated to be stabilized by USP7 in
            polyubiquitination degradation of p53.             hepatocellular  carcinoma  (HCC)  cells;  interestingly,  this
                                                               protein is the upstream of the Hippo signaling [107] . Taken
              In addition, UPS7 has been shown to have other   together, USP7, which regulates Hippo pathway, could
            substrate proteins, including PTEN, c-Maf, MafB, trans-  bea potential therapeutic target for HCC. In addition,
            activator of transcription, NAD-dependent deacetylase   the nuclear factor kappa light chain enhancer of activated
            sirtuin-1, BCR-ABL, GATA-binding factor 1 (also known   B cells (NF-κB) signal transduction pathway has been
            as GATA1), and ring finger protein 168 [10,20,21,24,38,49,51,110,123] .   described previously to participate in the development and
            Many of these proteins are associated with cell cycle, DNA   dysfunction of the immune system. Most of the proteins
            damage, regulation of transcription, and tumorigenesis. In   in this pathway are known to regulate biological processes,
            addition, some of the substrate proteins have been shown   such as innate and adaptive immunity, inflammation,
            to function as a mediator in certain signaling pathways,   and stress responses. USP7 stabilizes NF-κB signaling
            indicating the complexity of the substrate proteins function   and increases its transcription, leading to the expression
            in human cells, thus, more studies are required to explore   of downstream genes in response to the immune system
            and understand its functions.                      activation [127] .

            5. USP7 modulates signaling transduction           6. USP7 and diseases
            It has been reported that USP7 is involved in multiple
            cellular signaling pathways, such as PI3K/PTEN/AKT   6.1. The roles of USP7 in viral infection and
            signaling [10,124] ,  Wnt/β-catenin  signaling ,  Hippo  inflammation
                                                [39]
            pathway [107] , NF-κB signaling [125] , type I IFN signaling [126] ,   Interferon (IFN) is a low molecular glycoprotein induced
            and DNA damage signaling [110]  (Table 2). These pathways   by virus, bacteria, and IFN inducers acting on cells. IFN
            have  different  effects  on  cells,  although  their  activities   is not toxic to the cell itself, but it inhibits the replication
            are regulated by USP7. For example, in multiple cellular   of a variety of viruses and possesses antitumor activity [142] .


            Volume 1 Issue 2 (2022)                         5                      https://doi.org/10.36922/gpd.v1i2.118
   90   91   92   93   94   95   96   97   98   99   100